AI 创业公司融资日历

1819 家公司 1840 轮融资 306 家已接到招聘板 全部在招职位 →

💡 刚融资 = 正在扩招。 创业公司拿到钱第一件事就是扩团队——先到先得。看到心仪的公司刚融资,点"→ 在招岗位",趁招聘高峰投。

轮次 全部 Series ASeedSeries BSeries CSeries DPre-SeedGrowthSeries EDebtSeries FSeries G+RoundPrivate Equity
领域 全部 FinTechAI InfrastructureEnterprise SaaSDeveloper ToolsHealthcareHardware & RoboticsConsumerCybersecurityMarketing & AdTechData & AnalyticsPropTech & ConstructionInfrastructureClimate TechHR & Workforce
筛选 ✅ 只看正在招人的 ≥ $50M 2026 年 ✕ 清除全部

当前显示 19 轮 · 合计 $2.1B · 其中 7 家正在招人

2026 年 7月1 轮

Chai Discovery Series C $400M Biotech 累计 $625M
AI-based molecular interactions platform for drug discovery performing state-of-the-art structure prediction and antibody design

2026 年 6月3 轮

Cellares Series D $327M Biotech 累计 $682M
Cellares is an integrated development and manufacturing organization (IDMO) for cell therapies, using automation and industrial-scale manufacturing sy…
Collate Series B $95M Biotech 累计 $125M
AI document generation platform for life sciences that automates regulatory paperwork for diagnostic, medical device, and drug development companies. …
NewLimit Series C $435M Biotech 累计 $760M
NewLimit develops epigenetic reprogramming medicines to restore youthful cellular function and treat diseases with large unmet needs. Co-founded by Br…

2026 年 4月2 轮

Cresilon Debt $5M Biotech 累计 $148M
Cresilon develops hemostatic medical devices, including gel-based technologies that rapidly stop bleeding for human and animal care.
未接到招聘板 待核实
Sennos Series B $20M Biotech 累计 $50M
Sennos builds AI software for fluidics and fermentation operations, focusing on process monitoring, optimization, and bioprocess analytics.
未接到招聘板 待核实

2026 年 3月3 轮

Mantis Biotech Seed $7M Biotech
Mantis Biotech builds infrastructure powering human-in-computer models, combining LLMs with high-fidelity physics simulations to convert rare human be…
未接到招聘板 待核实
Science Series C $230M Biotech 累计 $490M
Science Corporation is a neural engineering company developing brain-computer interface (BCI) technology to restore and enhance human vision. The comp…
未接到招聘板 待核实
Astromech Seed $11M Biotech 累计 $41M
Astromech is an AI-and-biology startup recruiting across genomics, evolutionary modeling, synthetic data, and alignment research to decode and simulat…
未接到招聘板 待核实

2026 年 2月7 轮

Loyal Series C $100M Biotech 累计 $250M
Loyal is a clinical-stage veterinary medicine company developing longevity drugs to help dogs live longer, healthier lives. They are the first company…
未接到招聘板 待核实
Angitia Series D $130M Biotech 累计 $420M
Angitia is a biotechnology company developing novel therapies for endocrine and metabolic diseases, including rare disease programs.
未接到招聘板 待核实
Osmo Series B $70M Biotech 累计 $130M
Osmo uses AI-powered olfactory intelligence to digitize and generate custom scent formulas, building the world's first AI-powered fragrance house with…
Third Arc Bio Series A $52M Biotech 累计 $217M
Third Arc Bio is an immunology and inflammation-focused biotechnology company developing targeted immune therapeutics across oncology and inflammatory…
未接到招聘板 待核实
Expert Intelligence Seed $6M Biotech
Expert Intelligence builds an AI decision layer for laboratory workflows in pharma, materials, food, and environmental testing, emphasizing governed a…
未接到招聘板 待核实
Colossal Biosciences Series C $60M Biotech 累计 $615M
Colossal Biosciences is a genetic engineering and de-extinction company using CRISPR technology to restore extinct species like the woolly mammoth and…
Phylo Seed $14M Biotech
Phylo is an applied AI research laboratory developing Biomni Lab, an integrated workspace enabling scientists to plan, author, execute, and collaborat…

2026 年 1月3 轮

Breakthru Medicine Series A $60M Biotech
Breakthru Medicine is a biotech company developing novel oncology therapies, with a focus on first-in-class radioconjugate treatment approaches for ca…
未接到招聘板 待核实
Converge Bio Series A $25M Biotech 累计 $30M
Converge Bio develops generative AI platform trained on molecular data to help pharma and biotech companies discover and develop more effective drugs …
未接到招聘板 待核实
Prudentia Sciences Series A $20M Biotech 累计 $27M
Prudentia Sciences develops AI software for life-sciences diligence, asset valuation, and investment decision support across biopharma programs.
未接到招聘板 待核实